H.R. 3537 — Engrossed in House

114th CONGRESS 2d Session H. R. 3537 AN ACT To amend the Controlled Substances Act to add certain synthetic substances to schedule I, and for other purposes. 1. Short title This Act may be cited as the Dangerous Synthetic Drug Control Act of 2016. 2. Treatment of certain designer drugs as schedule I controlled substances (a) Cannabimimetic agents Schedule I, as set forth in section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)), is amended in subsection (d)(2)(B)— (1) in clause (xiv) by striking and at the end; (2) in clause (xv) by striking the period and inserting a semicolon; and (3) by adding at the end the following: (xvi) 2-(2-methylphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone (JWH–251); (xvii) (1-butyl-1H-indol-3-yl)(4-methylnaphthalen-1-yl)methanone (4′-methyl JWH–073); (xviii) 2-(3-methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone (JWH–302); (xix) N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (5F–APICA); (xx) quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5F–PB–22); (xxi) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB–PINACA); (xxii) N-(naphthalen-1-yl)-1-pentyl-1H-indole-3-carboxamide (MN–24); (xxiii) (1-(5-fluoropentyl)-1H-indazol-3-yl)(naphthalen-1-yl)methanone (THJ–2201); (xxiv) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (ADBICA); (xxv) methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (5F–AMB); and (xxvi) methyl 2-(1-(cyclohexylmethyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (MA–CHMINACA). . (b) Synthetic opioids Schedule I, as set forth in section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)), is amended in subsection (a) by adding at the end the following: (43) Butyryl fentanyl. (44) beta-Hydroxythiofentanyl. (45) Acetyl fentanyl. . (c) Other drugs Schedule I, as set forth in section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)), is amended in subsection (c) by adding at the end the following: (29) 1-(naphthalen-1-yl)-2-(pyrrolidin-1-yl)pentan-1-one (α-naphyrone). (30) 1-(2,3-dihydrobenzofuran-5-yl)propan-2-amine (5–APDB). (31) 1-(2,3-dihydrobenzofuran-6-yl)propan-2-amine (6–APDB). (32) 6,7-dihydro-5H-indeno[5,6-d][1,3]dioxol-6-amine (MDAI). (33) 5-iodo-2,3-dihydro-1H-inden-2-amine (5–IAI). (34) 1-(4-bromofuro[2,3-f]benzofuran-8-yl)propan-2-amine (bromo-dragonfly). (35) 1-(4-chloro-2,5-dimethoxyphenyl)propan-2-amine (DOC). (36) 1-(4-ethoxy-2,5-dimethoxyphenyl)propan-2-amine (MEM). . Passed the House of Representatives September 26, 2016.Clerk.